NIH's Commercialization Assistance Program (NIH-CAP) Accepts Akaza Research
Akaza Research, the leading provider of the OpenClinica® clinical trials software, announces that it has been accepted into the National Institutes of Health Commercialization Assistance Program (NIH-CAP).
Cambridge, MA (PRWEB) September 20, 2007 -- Akaza Research, the leading provider of the OpenClinica® clinical trials software, announces that it has been accepted into the National Institutes of Health Commercialization Assistance Program (NIH-CAP).
The NIH-CAP is a competitive NIH program designed to assist selected NIH SBIR Phase II grantees in brining their technology to market.
The NIH-CAP is funded by the National Institutes of Health and managed and executed by the Larta Institute, a global consultancy with clients such as IBM, Genzyme, and Allergan. According to Larta, "The program is designed to assist some of the most promising life science companies in bringing their technologies to market." Akaza will work with the Larta Institute to expand the presence of OpenClinica, the popular open source EDC system, in certain markets.
"We are pleased to have been accepted into this exclusive program and look forward to collaborating with the Larta Institute and NIH to bring OpenClinica into new markets," said Cal Collins, Chief Executive Officer at Akaza Research, LLC.
About OpenClinica®
OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. The current production release of OpenClinica is version 2.0.1. All versions of OpenClinica are available for download at http://www.OpenClinica.org.
About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See http://www.akazaresearch.com.
###
|
